Skip to content

Tempus AI, Inc. TEM Other accrued liabilities

Other accrued liabilities at other companies

IQVIA logo
IQVIAIQV
Natera, Inc. logo
Natera, Inc.NTRA
TEC
Bio-TechneTECH
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Roivant Sciences logo
Roivant SciencesROIV

Other financials

Income statement

See full
Revenue$348.1M+36.1%
Operating income-$84.7M-23.3%
Net income-$125.9M-85.1%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$525.9M+243%
Total debt$85.4M+49.8%
Total equity$416.4M+27.7%
Total assets$2.1B+38.4%

Cash flow

See full
Operating cash flow-$73.3M+30.6%
CapEx$8.2M+295%
Free cash flow-$81.5M+24.3%

Valuation

See full
Market cap$9.13B-2.7%
Enterprise value$8.69B-6.9%
P/S6.7×-5.0×

Profitability

See full
Operating margin-19.7%-8.6pp
Net margin-22.2%-9.5pp
FCF margin-54.5%

Returns & leverage

See full
Return on equity-81.6%
Debt / equity0.2×0.0×
Current ratio3.3×+1.6×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The official record: Tempus AI, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tempus AI, Inc.'s other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tempus AI, Inc.'s other accrued liabilities?
Tempus AI, Inc. (TEM) reported other accrued liabilities of $10.25M in Q1 2026.
How has Tempus AI, Inc.'s other accrued liabilities changed year-over-year?
Tempus AI, Inc.'s other accrued liabilities decreased by 43.7% year-over-year, from $18.19M to $10.25M.
What is the long-term trend for Tempus AI, Inc.'s other accrued liabilities?
Over 2 years (2023 to 2025), Tempus AI, Inc.'s other accrued liabilities has grown at a 2.8% compound annual growth rate (CAGR), from $8.21M to $8.68M.